Xcout Intel
LYTIX BIOPHARMA competitors & alternatives
The 12 closest competitors and alternatives to LYTIX BIOPHARMA among biotech companies — ranked by similarity to what LYTIX BIOPHARMA actually does, not by market-cap band.
Subscribe to see LYTIX BIOPHARMA’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About LYTIX BIOPHARMA
Lytix Biopharma is a clinical-stage biotechnology company developing oncolytic molecule therapies to treat superficial and deep-seated tumors. The company focuses on the neoadjuvant setting, providing first-in-class immunotherapies designed to destroy cancer cell membranes and stimulate a broad immune response.
LYTIX BIOPHARMA at a glance
LYTIX BIOPHARMA is a biotech company headquartered in Norway. Xcout tracks 6 named people at LYTIX BIOPHARMA, including Eric Falcand (Chairman of the Board).
LYTIX BIOPHARMA leadership
- Eric FalcandChairman of the Board
- Brynjar ForbergskogBoard Member
- Claus AnderssonBoard Member
- Darlene Deptula-HicksBoard Member
- Julie Dehaene-PuypeBoard Member
- Marie-Louise FjällskogBoard Member
Top 12 LYTIX BIOPHARMA competitors
Ranked by semantic similarity — how close each company is to LYTIX BIOPHARMA by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Surface Oncology is a clinical-stage biotechnology company focused on developing immunotherapies that target the tumor microenvironment and enhance anti-tumor immune responses. Its programs are intended for cancer patients and are developed for use by oncology physicians and healthcare systems, with potential pharmaceutical partnerships.
Similar biotech company
Oncolytics Biotech Inc. is a clinical-stage biotechnology company developing pelareorep, an investigational intravenously administered therapeutic. The company focuses on unleashing the power of the immune system and operates as a public company with a small team based in San Diego, California.
Biotechnology
Neotx Holdings Ltd. is a biopharmaceutical company that develops cancer therapeutics and immunotherapies. It conducts clinical trials and researches proprietary technologies aimed at advancing cancer treatment.
Biotechnology
CVBio is a biotechnology company that develops virus-driven immunotherapies, specifically utilizing engineered oncolytic adenoviruses to target and destroy resistant cancer cells. The company's platform is designed to treat aggressive cancers, including adult and pediatric brain tumors, by selectively infecting tumor cells and eliciting an anti-tumor immune response.
Similar biotech company
TILT Biotherapeutics is a Finnish biotechnology company developing tumor-targeted immunotherapies, including oncolytic adenoviruses designed to stimulate immune responses against solid tumors. Its therapies are intended for cancer patients and are developed through clinical and pharmaceutical partnerships.
Biotechnology
Western Oncolytics Ltd. is a cutting-edge biotechnology and pharmaceutical company headquartered in Pittsburgh, Pennsylvania, focused on developing novel cancer therapies and drug pipelines.
Similar biotech company
Altamira Therapeutics Ltd. is a biotechnology company developing RNA-based cancer therapies using its proprietary xPhore nanoparticle delivery technology. Its lead candidate, ATX-402, is designed to systemically deliver therapeutic mRNA to reprogram the tumor microenvironment and improve cancer immunotherapy outcomes for patients.
Similar biotech company
Adcytherix is a clinical-stage biopharmaceutical company that develops next-generation antibody-drug conjugates (ADCs) for oncology. The company combines clinically validated targets with innovative payloads derived from approved cancer drugs to treat resistant cancers and address unmet medical needs.
Biotechnology
Lyvgen Biopharma is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immune-oncology therapies. Founded in 2016, the company maintains its headquarters in Shanghai, China, alongside research facilities in Suzhou.
Biotechnology
IO Biotech, Inc. is a clinical-stage biopharmaceutical company that develops novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines. Its proprietary T-win® technology is designed to modulate the tumor microenvironment by targeting both tumor cells and immune-suppressive cells, aiming to improve treatment outcomes for patients with melanoma and other tumor types.
Biotechnology
TigaTx is a Boston-based biotechnology company founded in 2018 that is developing a pipeline of therapies targeting various cancer types and infectious diseases.
Biotechnology
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of LYTIX BIOPHARMA and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for LYTIX BIOPHARMAand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →